Instil Bio

TILNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$50.254 M

$7.41 +1.79%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$71.4M

Loss-making

Shares outstanding

6,781,976

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#126TScan TherapeuticsTCRX$52.0M
#127OKYO PharmaOKYO$50.4M
#128Instil BioTIL$50.3M
#129Atyr PharmaATYR$50.1M
#130Black Hawk AcquisitionBKHA$48.9M

Where these numbers come from

Share counts and financials for Instil Bio are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.